Free Trial
LON:N4P

N4 Pharma (N4P) Share Price, News & Analysis

N4 Pharma logo
GBX 0.63 +0.03 (+4.50%)
As of 07:14 AM Eastern

About N4 Pharma Stock (LON:N4P)

Advanced

Key Stats

Today's Range
0.55
0.65
50-Day Range
0.42
0.74
52-Week Range
0.35
1
Volume
654,066 shs
Average Volume
2.48 million shs
Market Capitalization
£5.22 million
P/E Ratio
N/A
Dividend Yield
3.12%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive N4P Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for N4 Pharma and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

N4P Stock News Headlines

N4 Pharma PLC reports change in major holdings
Forget AI, This Will Be the Next Big Tech Breakthrough
After picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be the biggest paradigm shift ever. Yes, even bigger than AI. And he found one Seattle company that's at the center of this new $100 trillion revolution. Click here to get the name of this company, completely free of charge...tc pixel
N4 Pharma PLC
N4 Pharma Plc Share Chat (N4P)
N4 Pharma PLC (N4P.AQ)
See More Headlines

N4P Stock Analysis - Frequently Asked Questions

N4 Pharma's stock was trading at GBX 0.54 at the beginning of 2025. Since then, N4P stock has increased by 17.2% and is now trading at GBX 0.63.

N4 Pharma Plc (LON:N4P) issued its earnings results on Thursday, September, 25th. The company reported ($0.09) earnings per share for the quarter. N4 Pharma had a negative net margin of 18,399.86% and a negative trailing twelve-month return on equity of 90.68%.

Shares of N4P stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that N4 Pharma investors own include 4D pharma (DDDD), Active Energy Group (AEG), B&M European Value Retail (BME), BP (BP), Coats Group (COA), EQTEC (EQT) and genedrive (GDR).

Company Calendar

Last Earnings
9/25/2025
Today
10/10/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
LON:N4P
CIK
N/A
Fax
N/A
Employees
5
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX 0
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£1.63 million
Net Margins
-18,399.86%
Pretax Margin
N/A
Return on Equity
-90.68%
Return on Assets
-56.00%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
22.73
Quick Ratio
7.28

Sales & Book Value

Annual Sales
£7.07 thousand
Price / Sales
738.52
Cash Flow
GBX 0.28 per share
Price / Cash Flow
2.25
Book Value
GBX 0.45 per share
Price / Book
1.40

Miscellaneous

Outstanding Shares
832,280,000
Free Float
N/A
Market Cap
£5.22 million
Optionable
Not Optionable
Beta
-0.37
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (LON:N4P) was last updated on 10/10/2025 by MarketBeat.com Staff
From Our Partners